AA-type amyloidosis associated with lymphoma: a study of 19 cases including 5 new French cases and a systematic literature review

References

• Basset M, Defrancesco I, Milani P, et al. Light chain amyloidosis and non-Hodgkin’s lymphomas: a peculiar association with distinct clinical features and outcome. Blood. 2018;132(Supplement 1):2026–2026. doi:10.1182/blood-2018-99-118161
   PubMedGoogle Scholar
• Forget BG, Squires JW, Sheldon H. Waldenström’s macroglobulinemia with generalized amyloidosis. Arch Intern Med. 1966;118(4):363–375. doi:10.1001/archinte.1966.00290160063013
   PubMedGoogle Scholar
• Cohen AD, Zhou P, Xiao Q, et al. Systemic AL amyloidosis due to non-Hodgkin’s lymphoma: an unusual clinicopathologic association: AL with NHL. Br J Haematol. 2004;124(3):309–314. doi:10.1046/j.1365-2141.2003.04779.x
   PubMed Web of Science ®Google Scholar
• Basset M, Defrancesco I, Milani P, et al. Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis. Blood. 2020;135(4):293–296. doi:10.1182/blood.2019002762
   PubMed Web of Science ®Google Scholar
• Scarpioni R, Ricardi M, Albertazzi V. Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage. World J Nephrol. 2016;5(1):66–75. doi:10.5527/wjn.v5.i1.66
   PubMedGoogle Scholar
• Sack GH. Serum amyloid a – a review. Mol Med. 2018;24(1):46. doi:10.1186/s10020-018-0047-0
   PubMedGoogle Scholar
• Westermark GT, Fändrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol. 2015;10(1):321–344. doi:10.1146/annurev-pathol-020712-163913
   PubMedGoogle Scholar
• Brunger AF, Nienhuis HLA, Bijzet J, et al. Causes of AA amyloidosis: a systematic review. Amyloid. 2020;27(1):1–12. doi:10.1080/13506129.2019.1693359
   PubMed Web of Science ®Google Scholar
• Alves P, Góis M, Mendes M, et al. Non-Hodgkin lymphoma–associated AA amyloidosis. J Onco-Nephrol. 2020;4(3):92–95. doi:10.1177/2399369320929340
   Google Scholar
• Demir F, Bahadir A, Mungan S, et al. Systemic amyloidosis in a patient with familial mediterranean fever and Hodgkin lymphoma: a case report. J Pediatr Hematol Oncol. 201942(3):234–237.
   PubMed Web of Science ®Google Scholar
• Hiasa Y, Konishi N, Kitahori Y, et al. ‘Secondary systemic amyloidosis with hodgkin’s disease. Acta Pathol Jpn. 1983;33(5):1069–1077. doi:10.1111/j.1440-1827.1983.tb02152.x
   PubMedGoogle Scholar
• Kubo Y, Tasaka T, Sano F, et al. Amyloid-associated amyloidosis in a HCV carrier with non-Hodgkin’s lymphoma who had been treated with autologous stem cell transplantation and rituximab. Leuk Lymphoma. 2007;48(10):2075–2078. doi:10.1080/10428190701606842
   PubMed Web of Science ®Google Scholar
• Manwani R, Wrench D, Wechalekar A, et al. Successful treatment of systemic AA amyloidosis associated with underlying Hodgkin lymphoma. Br J Haematol. 2018;182(5):619–619. doi:10.1111/bjh.15269
   PubMed Web of Science ®Google Scholar
• Pamuk GE, Demir M, Örüm H, et al. Secondary amyloidosis causing nephrotic syndrome in a patient with non-Hodgkin’s lymphoma: quite a rare diagnosis: diagnosis of secondary amyloidosis in NHL patient. Clin Lab Haematol. 2006;28(4):259–261. doi:10.1111/j.1365-2257.2006.00795.x
   PubMedGoogle Scholar
• P. Pfitzenmeyer, F. Massin, P. Fargeot, P. Bonneau, R. Michiels, L. Jeannin, Amyloïdose pulmonaire de type AA associée à une maladie de Hodgkin, La Revue de Médecine Interne, 1988, 9(5):524–527, ISSN 0248-8663, https://doi.org/10.1016/S0248-8663(88)80018-3.
   Google Scholar
• Piskin O, Alacacioglu I, Ozkal S, et al. A patient with diffuse large B-cell non-Hodgkin’s lymphoma and AA type amyloidosis. J BUON. 2008;13(1):113–116.
   PubMed Web of Science ®Google Scholar
• Salihoglu A, Elverdi T, Keskin D, et al. P059 (0114) AA amyloidosis causing nephrotic syndrome in two patients with hodgkin lymphoma. HemaSphere. 2018;2:23.
   Google Scholar
• Shaulov A, Prus D, Lavie D, et al. Duodenal amyloid a depositions in a patient with refractory Hodgkin’s lymphoma: an old complication in the modern treatment era. Amyloid. 2018;25(4):263–264. doi:10.1080/13506129.2018.1517737
   PubMed Web of Science ®Google Scholar
• Tajima S, Ushijima T, Matuya S, et al. AA-type amyloidosis in association with non-Hodgkin’s lymphoma following CMV viremia: autopsy case. Pathol Int. 2010;60(3):222–227. doi:10.1111/j.1440-1827.2009.02505.x
   PubMed Web of Science ®Google Scholar
• Xicoy B, Ribera JM, Vaquero M, et al. AA-type amyloid tumor as an unsuspected cause of residual mass in a patient with large B-cell non-Hodgkin’s lymphoma. Leuk Lymphoma. 2002;43(3):681–682. doi:10.1080/10428190290012290
   PubMed Web of Science ®Google Scholar
• Zhu LC, Sidhu GS, Yee HT, et al. AA-type amyloidosis associated with non-Hodgkin’s lymphoma: a case report. Hum Pathol. 2004;35(8):1041–1044. doi:10.1016/j.humpath.2004.05.004
   PubMed Web of Science ®Google Scholar
• Levin LI, Breen EC, Birmann BM, et al. Elevated serum levels of sCD30 and IL6 and detectable IL10 precede classical Hodgkin lymphoma diagnosis. Cancer Epidemiol Biomarkers Prev. 2017;26(7):1114–1123. doi:10.1158/1055-9965.EPI-16-1012
   PubMed Web of Science ®Google Scholar
• Stankovic Stojanovic K, Georgin-Lavialle S, Poitou C, et al. AA amyloidosis is an emerging cause of nephropathy in obese patients. Eur J Intern Med. 2017;39:e18–e20. doi:10.1016/j.ejim.2017.02.004
   PubMed Web of Science ®Google Scholar
• Ibrahim A, Hamza A, Khurram M, et al. Chronic hepatitis C virus and its relation to secondary amyloid nephropathy: case series and literature review. Am J Clin Pathol. 2015;144(suppl 2):A315–A315. doi:10.1093/ajcp/144.suppl2.315
   PubMedGoogle Scholar
• Harris M, Brathwaite R, Scott J, et al. Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs: AA amyloidosis among PWID. Addiction. 2018;113(10):1790–1801. doi:10.1111/add.14257
   PubMed Web of Science ®Google Scholar
• Akar N, Hasipek M, Akar E, et al. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial mediterranean fever patients with and without amyloidosis. Amyloid. 2003;10(1):12–16. doi:10.3109/13506120308995251
   PubMed Web of Science ®Google Scholar
• Bharati J, Lahoud OB, Jhaveri KD, et al. AA amyloidosis associated with cancers. Nephrol Dial Transplant. 2023;38(6):1366–1374. doi:10.1093/ndt/gfac217
   PubMed Web of Science ®Google Scholar